The case for altruism in institutional diagnostic testing
- PMID: 35115545
- PMCID: PMC8813946
- DOI: 10.1038/s41598-021-02605-4
The case for altruism in institutional diagnostic testing
Abstract
Amid COVID-19, many institutions deployed vast resources to test their members regularly for safe reopening. This self-focused approach, however, not only overlooks surrounding communities but also remains blind to community transmission that could breach the institution. To test the relative merits of a more altruistic strategy, we built an epidemiological model that assesses the differential impact on case counts when institutions instead allocate a proportion of their tests to members' close contacts in the larger community. We found that testing outside the institution benefits the institution in all plausible circumstances, with the optimal proportion of tests to use externally landing at 45% under baseline model parameters. Our results were robust to local prevalence, secondary attack rate, testing capacity, and contact reporting level, yielding a range of optimal community testing proportions from 18 to 58%. The model performed best under the assumption that community contacts are known to the institution; however, it still demonstrated a significant benefit even without complete knowledge of the contact network.
© 2022. The Author(s).
Conflict of interest statement
Pardis C. Sabeti is a co-founder and shareholder of Sherlock Biosciences and is a non-executive board member and shareholder of Danaher Corporation. Andrés Colubri and Pardis C. Sabeti are inventors on patents related to diagnostics and Bluetooth-based contact tracing tools and technologies filed with the USPTO and other intellectual property bodies. All other authors declare no competing interests.
Figures



References
-
- White M. A Kantian-economic approach to altruism in the household. Palgrave Commun. 2015;1:15005. doi: 10.1057/palcomms.2015.5. - DOI
-
- Mack CD, Wasserman EB, Perrine CG, MacNeil A, Anderson DJ, Mayers E, et al. Implementation and evolution of mitigation measures, testing, and contact tracing in the national football league, August 9-November 21, 2020. MMWR Morb. Mortal Wkly. Rep. 2021;70:130–135. doi: 10.15585/mmwr.mm7004e2. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical